Skip to main content

Beacon Therapeutics

Alachua, United States

Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.

$75.0M raised
Jan 2026
Series C

Top Investors

TCG CrossoverOxford Science EnterprisesForbion Capital PartnersGoldman Sachs AlternativesUniversity of Oxford

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Beacon Therapeutics

How much funding has Beacon Therapeutics raised?
Beacon Therapeutics has raised $75.0M in total funding. The most recent round was Series C. The last funding was announced in January 2026.
Who are Beacon Therapeutics's investors?
Beacon Therapeutics's investors include TCG Crossover, Oxford Science Enterprises, Forbion Capital Partners, Goldman Sachs Alternatives, University of Oxford.
Where is Beacon Therapeutics headquartered?
Beacon Therapeutics is headquartered in Alachua, United States.
What does Beacon Therapeutics do?
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
What stage is Beacon Therapeutics at?
Beacon Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Beacon Therapeutics — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/beacon-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2026). Beacon Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/beacon-therapeutics
Wikipedia (cite web)
{{cite web |title=Beacon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/beacon-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .